ketamine has been researched along with Dementia in 8 studies
Ketamine: A cyclohexanone derivative used for induction of anesthesia. Its mechanism of action is not well understood, but ketamine can block NMDA receptors (RECEPTORS, N-METHYL-D-ASPARTATE) and may interact with sigma receptors.
ketamine : A member of the class of cyclohexanones in which one of the hydrogens at position 2 is substituted by a 2-chlorophenyl group, while the other is substituted by a methylamino group.
Dementia: An acquired organic mental disorder with loss of intellectual abilities of sufficient severity to interfere with social or occupational functioning. The dysfunction is multifaceted and involves memory, behavior, personality, judgment, attention, spatial relations, language, abstract thought, and other executive functions. The intellectual decline is usually progressive, and initially spares the level of consciousness.
Excerpt | Relevance | Reference |
---|---|---|
" The current case report describes a patient suffering from severe depression and dementia who received electroconvulsive therapy with S-ketamine anesthesia at our psychiatric intensive care unit for the treatment of her therapy-resistant catatonic stupor." | 7.85 | Electroconvulsive therapy with S-ketamine anesthesia for catatonia in coexisting depression and dementia. ( Bauer, M; Frey, R; Kasper, S; Litvan, Z, 2017) |
"Depression is a common psychiatric symptom in numerous neurological disorders." | 6.82 | (R)-ketamine as prophylactic and therapeutic drug for neurological disorders: Beyond depression. ( Hashimoto, K; Wang, X; Yang, J, 2022) |
" The current case report describes a patient suffering from severe depression and dementia who received electroconvulsive therapy with S-ketamine anesthesia at our psychiatric intensive care unit for the treatment of her therapy-resistant catatonic stupor." | 3.85 | Electroconvulsive therapy with S-ketamine anesthesia for catatonia in coexisting depression and dementia. ( Bauer, M; Frey, R; Kasper, S; Litvan, Z, 2017) |
"Depression is a common psychiatric symptom in numerous neurological disorders." | 2.82 | (R)-ketamine as prophylactic and therapeutic drug for neurological disorders: Beyond depression. ( Hashimoto, K; Wang, X; Yang, J, 2022) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 2 (25.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (37.50) | 24.3611 |
2020's | 3 (37.50) | 2.80 |
Authors | Studies |
---|---|
Mielke, N | 1 |
Johnson, S | 1 |
Bahl, A | 1 |
Fadladdin, YAJ | 1 |
Xue, M | 1 |
Zhang, X | 1 |
Chen, J | 1 |
Liu, F | 1 |
Xu, J | 1 |
Xie, J | 1 |
Yang, Y | 1 |
Yu, W | 1 |
Qiu, H | 1 |
Xue, J | 1 |
Jiang, J | 1 |
Liu, Y | 2 |
Shallom, SJ | 1 |
Zelazny, AM | 1 |
Giri, AR | 1 |
Kaur, N | 1 |
Yarrarapu, SNS | 1 |
Rottman Pietrzak, KA | 1 |
Santos, C | 1 |
Lowman, PE | 1 |
Niaz, S | 1 |
Franco, PM | 1 |
Sanghavi, DK | 1 |
Zhu, D | 1 |
Liang, R | 1 |
Li, Z | 2 |
Cheng, L | 1 |
Ren, J | 1 |
Guo, Y | 1 |
Wang, M | 1 |
Chai, H | 1 |
Niu, Q | 1 |
Yang, S | 1 |
Bai, J | 1 |
Yu, H | 1 |
Zhang, H | 1 |
Qin, X | 1 |
Sahrakorpi, N | 1 |
Engberg, E | 1 |
Stach-Lempinen, B | 1 |
Tammelin, TH | 1 |
Kulmala, J | 1 |
Roine, RP | 1 |
Koivusalo, SB | 1 |
Cheng, W | 1 |
Pang, H | 1 |
Campen, MJ | 1 |
Zhang, J | 2 |
Li, Y | 1 |
Gao, J | 1 |
Ren, D | 1 |
Ji, X | 1 |
Rothman, N | 1 |
Lan, Q | 1 |
Zheng, Y | 1 |
Leng, S | 1 |
Hu, Z | 1 |
Tang, J | 1 |
Dong, Q | 1 |
Song, N | 1 |
Qin, N | 1 |
Chen, C | 1 |
Sun, X | 1 |
Easton, J | 1 |
Mulder, H | 1 |
Plyler, E | 1 |
Neale, G | 1 |
Walker, E | 1 |
Li, Q | 1 |
Ma, X | 1 |
Chen, X | 1 |
Huang, IC | 1 |
Yasui, Y | 1 |
Ness, KK | 1 |
Hudson, MM | 1 |
Robison, LL | 1 |
Wang, Z | 1 |
Subota, A | 1 |
Spotswood, N | 1 |
Roach, M | 1 |
Goodarzi, Z | 1 |
Holroyd-Leduc, J | 1 |
Park, EA | 1 |
Graves, SA | 1 |
Menda, Y | 1 |
Wang, X | 1 |
Yang, J | 1 |
Hashimoto, K | 1 |
Wu, S | 1 |
Ji, H | 1 |
Won, J | 1 |
Jo, EA | 1 |
Kim, YS | 1 |
Park, JJ | 1 |
Eldufani, J | 1 |
Nekoui, A | 1 |
Blaise, G | 1 |
Nanagas, K | 1 |
Avera, R | 1 |
Purpura, A | 1 |
Murphy, J | 1 |
Kao, L | 1 |
Litvan, Z | 1 |
Bauer, M | 1 |
Kasper, S | 1 |
Frey, R | 1 |
Ellison, G | 1 |
Yonou, H | 1 |
Kagawa, H | 1 |
Oda, A | 1 |
Nagano, M | 1 |
Gakiya, M | 1 |
Niimura, K | 1 |
Hatano, T | 1 |
Ogawa, Y | 1 |
4 reviews available for ketamine and Dementia
Article | Year |
---|---|
Topics: Adult; Aging; Aluminum; Alzheimer Disease; Animals; Anti-Bacterial Agents; Artemisia annua; Body Mas | 2022 |
(R)-ketamine as prophylactic and therapeutic drug for neurological disorders: Beyond depression.
Topics: Antidepressive Agents; Dementia; Depression; Humans; Ketamine; Nervous System Diseases; Stroke | 2022 |
Nonanesthetic Effects of Ketamine: A Review Article.
Topics: Chronic Pain; Cognition; Dementia; Depression; Excitatory Amino Acid Antagonists; Humans; Ketamine | 2018 |
The N-methyl-D-aspartate antagonists phencyclidine, ketamine and dizocilpine as both behavioral and anatomical models of the dementias.
Topics: Animals; Behavior, Animal; Dementia; Disease Models, Animal; Dizocilpine Maleate; Humans; Ketamine; | 1995 |
1 trial available for ketamine and Dementia
Article | Year |
---|---|
The Effects of Exergaming on Executive and Physical Functions in Older Adults With Dementia: Randomized Controlled Trial.
Topics: Aged; Cognition; Cognitive Behavioral Therapy; Dementia; Exercise; Exergaming; Humans; Ketamine | 2023 |
3 other studies available for ketamine and Dementia
Article | Year |
---|---|
Articles You May Have Missed.
Topics: Alcohol Withdrawal Delirium; Antidotes; Carbon Monoxide Poisoning; Chemical and Drug Induced Liver I | 2018 |
Electroconvulsive therapy with S-ketamine anesthesia for catatonia in coexisting depression and dementia.
Topics: Aged; Anesthesia; Catatonia; Dementia; Depressive Disorder, Major; Electroconvulsive Therapy; Female | 2017 |
[Transurethral resection of the prostate for patients with dementia].
Topics: Aged; Aged, 80 and over; Anesthesia, Spinal; Anesthetics, Dissociative; Anesthetics, Intravenous; De | 1999 |